BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15643881)

  • 1. Interaction between the type-3 copper protein tyrosinase and the substrate analogue p-nitrophenol studied by NMR.
    Tepper AW; Bubacco L; Canters GW
    J Am Chem Soc; 2005 Jan; 127(2):567-75. PubMed ID: 15643881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paramagnetic properties of the halide-bound derivatives of oxidised tyrosinase investigated by 1H NMR spectroscopy.
    Tepper AW; Bubacco L; Canters GW
    Chemistry; 2006 Oct; 12(29):7668-75. PubMed ID: 16927257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-ray absorption analysis of the active site of Streptomyces antibioticus Tyrosinase upon binding of transition state analogue inhibitors.
    Bubacco L; Spinazze R; della Longa S; Benfatto M
    Arch Biochem Biophys; 2007 Sep; 465(2):320-7. PubMed ID: 17698026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of Streptomyces antibioticus tyrosinase reactivity toward chlorophenols.
    Marino SM; Fogal S; Bisaglia M; Moro S; Scartabelli G; De Gioia L; Spada A; Monzani E; Casella L; Mammi S; Bubacco L
    Arch Biochem Biophys; 2011 Jan; 505(1):67-74. PubMed ID: 20875779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A strategy for the NMR characterization of type II copper(II) proteins: the case of the copper trafficking protein CopC from Pseudomonas Syringae.
    Arnesano F; Banci L; Bertini I; Felli IC; Luchinat C; Thompsett AR
    J Am Chem Soc; 2003 Jun; 125(24):7200-8. PubMed ID: 12797793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stopped-flow fluorescence studies of inhibitor binding to tyrosinase from Streptomyces antibioticus.
    Tepper AW; Bubacco L; Canters GW
    J Biol Chem; 2004 Apr; 279(14):13425-34. PubMed ID: 14699163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectroscopic characterization of the electronic changes in the active site of Streptomyces antibioticus tyrosinase upon binding of transition state analogue inhibitors.
    Bubacco L; Van Gastel M; Groenen EJ; Vijgenboom E; Canters GW
    J Biol Chem; 2003 Feb; 278(9):7381-9. PubMed ID: 12473668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EPR study of the dinuclear active copper site of tyrosinase from Streptomyces antibioticus.
    van Gastel M; Bubacco L; Groenen EJ; Vijgenboom E; Canters GW
    FEBS Lett; 2000 Jun; 474(2-3):228-32. PubMed ID: 10838090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis and mechanism of the inhibition of the type-3 copper protein tyrosinase from Streptomyces antibioticus by halide ions.
    Tepper AW; Bubacco L; Canters GW
    J Biol Chem; 2002 Aug; 277(34):30436-44. PubMed ID: 12048185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1H NMR spectroscopy of the binuclear Cu(II) active site of Streptomyces antibioticus tyrosinase.
    Bubacco L; Salgado J; Tepper AW; Vijgenboom E; Canters GW
    FEBS Lett; 1999 Jan; 442(2-3):215-20. PubMed ID: 9929004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxygen binding to tyrosinase from streptomyces antibioticus studied by laser flash photolysis.
    Hirota S; Kawahara T; Lonardi E; de Waal E; Funasaki N; Canters GW
    J Am Chem Soc; 2005 Dec; 127(51):17966-7. PubMed ID: 16366523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan-to-dye fluorescence energy transfer applied to oxygen sensing by using type-3 copper proteins.
    Zauner G; Lonardi E; Bubacco L; Aartsma TJ; Canters GW; Tepper AW
    Chemistry; 2007; 13(25):7085-90. PubMed ID: 17577913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First structures of an active bacterial tyrosinase reveal copper plasticity.
    Sendovski M; Kanteev M; Ben-Yosef VS; Adir N; Fishman A
    J Mol Biol; 2011 Jan; 405(1):227-37. PubMed ID: 21040728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The active-site structure of umecyanin, the stellacyanin from horseradish roots.
    Dennison C; Harrison MD
    J Am Chem Soc; 2004 Mar; 126(8):2481-9. PubMed ID: 14982457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the interaction of N/S compounds with a dicopper center: tyrosinase inhibition and model studies.
    Buitrago E; Vuillamy A; Boumendjel A; Yi W; Gellon G; Hardré R; Philouze C; Serratrice G; Jamet H; Réglier M; Belle C
    Inorg Chem; 2014 Dec; 53(24):12848-58. PubMed ID: 25415587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unprecedented binding cooperativity between Cu(I) and Cu(II) in the copper resistance protein CopK from Cupriavidus metallidurans CH34: implications from structural studies by NMR spectroscopy and X-ray crystallography.
    Chong LX; Ash MR; Maher MJ; Hinds MG; Xiao Z; Wedd AG
    J Am Chem Soc; 2009 Mar; 131(10):3549-64. PubMed ID: 19236095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of trypsin to a copper enzyme: tyrosinase/catechol oxidase by chemical modification.
    Okutucu B; Zeytunluoglu A; Zihnioglu F
    Prep Biochem Biotechnol; 2010; 40(1):88-96. PubMed ID: 20024799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trapping tyrosinase key active intermediate under turnover.
    Spada A; Palavicini S; Monzani E; Bubacco L; Casella L
    Dalton Trans; 2009 Sep; (33):6468-71. PubMed ID: 19672489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific interactions of Cu(II) with alpha and beta-synuclein: bridging the molecular gap between metal binding and aggregation.
    Binolfi A; Lamberto GR; Duran R; Quintanar L; Bertoncini CW; Souza JM; Cerveñansky C; Zweckstetter M; Griesinger C; Fernández CO
    J Am Chem Soc; 2008 Sep; 130(35):11801-12. PubMed ID: 18693689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the human prion PrP(106-126) sequence with copper(II), manganese(II), and zinc(II): NMR and EPR studies.
    Gaggelli E; Bernardi F; Molteni E; Pogni R; Valensin D; Valensin G; Remelli M; Luczkowski M; Kozlowski H
    J Am Chem Soc; 2005 Jan; 127(3):996-1006. PubMed ID: 15656638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.